Cite
HARVARD Citation
Dhere, V. et al. (2018). Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia. Leukemia & lymphoma. 59 (4), pp. 837-843. [Online].